The Defence Study

The study drug is a potential new treatment for complement pathway disorders. The complement pathway is an important part of our immune system, but it can cause a range of serious medical conditions if it malfunctions.

There is an ongoing need to develop better treatment options that can improve the quality of care provided to these patients.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time completing the study, up to $9,710.

Call us on 1800 243 733 to discuss your eligibility today!